Pohl-Rescigno, E., Hauke, J., Loibl, S., Möbus, V., Denkert, C., Fasching, P. A., . . . Hahnen, E. (2020). Association of germline variant status with therapy response in high-risk early-stage breast cancer: A secondary analysis of the geparOcto randomized clinical trial. JAMA oncology, 6(5), . https://doi.org/10.1001/jamaoncol.2020.0007
Chicago-Zitierstil (17. Ausg.)Pohl-Rescigno, Esther, et al. "Association of Germline Variant Status with Therapy Response in High-risk Early-stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial." JAMA Oncology 6, no. 5 (2020). https://doi.org/10.1001/jamaoncol.2020.0007.
MLA-Zitierstil (9. Ausg.)Pohl-Rescigno, Esther, et al. "Association of Germline Variant Status with Therapy Response in High-risk Early-stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial." JAMA Oncology, vol. 6, no. 5, 2020, https://doi.org/10.1001/jamaoncol.2020.0007.